1955
DOI: 10.1136/jnnp.18.4.237
|View full text |Cite
|
Sign up to set email alerts
|

The Blood-Cerebrospinal Fluid Barrier in Tuberculous Meningitis and Allied Conditions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
2
0

Year Published

1960
1960
2012
2012

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(4 citation statements)
references
References 13 publications
2
2
0
Order By: Relevance
“…When small numbers of virulent cryptococci were injected intravenously into normal mice, tissue populations rose markedly in all organs studies during s Unpublished studies by the author have demonstrated that the blood-cerebrospinal fluid bromide ratio fails from the normal 2.5 to 3.0:1 to 1:1 in cryptococeal meningitis in man. These findings are similar to those found in tuberculous meningitis (33) and indicate a marked alteration in the blood-cerebrospinal fluid barrier.…”
Section: Discussionsupporting
confidence: 88%
“…When small numbers of virulent cryptococci were injected intravenously into normal mice, tissue populations rose markedly in all organs studies during s Unpublished studies by the author have demonstrated that the blood-cerebrospinal fluid bromide ratio fails from the normal 2.5 to 3.0:1 to 1:1 in cryptococeal meningitis in man. These findings are similar to those found in tuberculous meningitis (33) and indicate a marked alteration in the blood-cerebrospinal fluid barrier.…”
Section: Discussionsupporting
confidence: 88%
“…Both returned to normal as the meningitis re gressed. No changes in bromide transfer were noted in other types of lympho cytic meningitis (96). Similar qualitative observations have been made for penicillin (98), and oxytetracycline (99).…”
Section: Clinical Implications Of Blood-brain Barrier Studiessupporting
confidence: 67%
“…Initially, patients with tuberculous meningitis were treated with PPD intrathecally with the aim of creating a sterile meningitis and thereby increase, because of the resultant breakdown of BBB, the delivery of the systemic antituberculous drugs within the CNS. The Oxford workers noticed an apparent success with this treatment (intrathecal PPD) in MS patients who also suffered from tuberculous meninigitis (Smith et al ., 1955). This formed the basis of a controlled trial of intrathecal tuberculin (PPD) in MS (Kelly and Jellinek, 1961).…”
Section: Discussionmentioning
confidence: 99%